CARDIAC ARRHYTHMIAS IN SPINAL TUBERCULOSIS A narrative review of potential mechanisms clinical assessment and evidence gaps

Authors

Keywords:

spinal tuberculosis; tuberculous spondylitis; cardiac arrhythmia; QT interval; autonomic dysfunction; electrocardiography; Holter monitoring.

Abstract

Background: Spinal tuberculosis can coexist with neurological impairment, systemic illness and cardiovascular comorbidity. Arrhythmias detected during its course may reflect several overlapping processes, including pre-existing heart disease, autonomic disturbance, metabolic abnormalities, medication effects and, occasionally, myocardial tuberculosis. The strength of evidence differs substantially across these explanations. 

Objective: To critically examine evidence relevant to cardiac arrhythmias in spinal tuberculosis and identify a clinically useful framework for assessment and future research.

Methods: A focused narrative review used targeted web searches to identify indexed biomedical publications and professional guidance available by 21 September 2026. Sources were selected for relevance to spinal tuberculosis, tuberculosis treatment and repolarization, myocardial involvement, spinal cord dysfunction and electrocardiographic assessment. Direct spinal evidence was distinguished from evidence extrapolated from other populations. No meta-analysis or formal risk-of-bias assessment was undertaken.

Synthesis: The selected literature supports the clinical relevance of treatment-associated QT prolongation and demonstrates altered cardiac autonomic regulation after traumatic spinal cord injury. However, neither finding establishes the incidence or mechanism of arrhythmias in spinal tuberculosis. QT prolongation is a marker of repolarization disturbance rather than an arrhythmia diagnosis. Published myocardial tuberculosis cases support a differential diagnosis but cannot quantify population risk. Baseline rhythm documentation, treatment timelines, electrolyte assessment and clinically indicated ambulatory monitoring are therefore central to interpretation.

Conclusion: Cardiac rhythm abnormalities in spinal tuberculosis require individualized attribution. Prospective studies should distinguish documented pre-existing arrhythmia from arrhythmia first detected after tuberculosis diagnosis, use comparable monitoring across groups and assess neurological, cardiac and treatment-related exposures separately.

 

References

1.Komilovich, E. B. (2026). INCIDENCE OF GASTRIC AND DUODENAL ULCER IN PATIENTS WITH PULMONARY TUBERCULOSIS. BG pulse journal, 2(5), 957-959.

2.World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment and care. Geneva: World Health Organization; 2025. https://tbksp.who.int/en/node/2951

3.Dooley KE, Rosenkranz SL, Conradie F, et al. QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial. Lancet Infect Dis. 2021;21(7):975–983. https://doi.org/10.1016/S1473-3099(20)30770-2

4.Tanneau L, Karlsson MO, Rosenkranz SL, et al. Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens. Clin Pharmacol Ther. 2022;112(4):873–881. https://doi.org/10.1002/cpt.2685

5.Malmqvist L, Biering-Sørensen T, Bartholdy K, et al. Assessment of autonomic function after acute spinal cord injury using heart rate variability analyses. Spinal Cord. 2015;53:54–58. https://doi.org/10.1038/sc.2014.195

6.Bartholdy K, Biering-Sørensen T, Malmqvist L, et al. Cardiac arrhythmias the first month after acute traumatic spinal cord injury. J Spinal Cord Med. 2014;37(2):162–170. https://doi.org/10.1179/2045772313Y.0000000181

7.Vennamaneni V, Chohan F, Rad P, Rodriguez J, Gupta R, Michel G. Clinical Presentation of a Patient With Tuberculous Myocarditis: Case Report and Review of Literature. Cureus. 2022;14(2):e22715. https://doi.org/10.7759/cureus.22715

8.Shaikh GA, et al. A rare case of tuberculous myocarditis: A diagnostic challenge in a tuberculosis-endemic country. Clin Case Rep. 2023;11:e8224. https://doi.org/10.1002/ccr3.8224

9.Tisdale JE, Chung MK, Campbell KB, et al. Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association. Circulation. 2020;142:e214–e233. https://doi.org/10.1161/CIR.0000000000000905

10.Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121:1047–1060. https://doi.org/10.1161/CIRCULATIONAHA.109.192704

11.Steinberg JS, Varma N, Cygankiewicz I, et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Heart Rhythm. 2017;14(7):e55–e96. https://doi.org/10.1016/j.hrthm.2017.03.038

12.Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93(5):1043–1065. https://doi.org/10.1161/01.CIR.93.5.1043

Published

2026-09-25